nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Erythema multiforme—Estradiol—osteoporosis	0.000507	0.000507	CcSEcCtD
Methylphenidate—Convulsion—Conjugated Estrogens—osteoporosis	0.000506	0.000506	CcSEcCtD
Methylphenidate—Dry mouth—Zoledronate—osteoporosis	0.000505	0.000505	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000504	0.000504	CcSEcCtD
Methylphenidate—Fatigue—Ethinyl Estradiol—osteoporosis	0.000504	0.000504	CcSEcCtD
Methylphenidate—Pruritus—Alendronate—osteoporosis	0.000502	0.000502	CcSEcCtD
Methylphenidate—Dyspepsia—Risedronate—osteoporosis	0.000501	0.000501	CcSEcCtD
Methylphenidate—Eye disorder—Estradiol—osteoporosis	0.000501	0.000501	CcSEcCtD
Methylphenidate—Constipation—Ethinyl Estradiol—osteoporosis	0.0005	0.0005	CcSEcCtD
Methylphenidate—Confusional state—Zoledronate—osteoporosis	0.000499	0.000499	CcSEcCtD
Methylphenidate—Hypersensitivity—Calcitriol—osteoporosis	0.000499	0.000499	CcSEcCtD
Methylphenidate—Cardiac disorder—Estradiol—osteoporosis	0.000498	0.000498	CcSEcCtD
Methylphenidate—Flushing—Estradiol—osteoporosis	0.000498	0.000498	CcSEcCtD
Methylphenidate—Myalgia—Conjugated Estrogens—osteoporosis	0.000497	0.000497	CcSEcCtD
Methylphenidate—Arthralgia—Conjugated Estrogens—osteoporosis	0.000497	0.000497	CcSEcCtD
Methylphenidate—Chest pain—Conjugated Estrogens—osteoporosis	0.000497	0.000497	CcSEcCtD
Methylphenidate—Asthenia—Ibandronate—osteoporosis	0.000496	0.000496	CcSEcCtD
Methylphenidate—Anxiety—Conjugated Estrogens—osteoporosis	0.000495	0.000495	CcSEcCtD
Methylphenidate—Nausea—Etidronic acid—osteoporosis	0.000495	0.000495	CcSEcCtD
Methylphenidate—Anaphylactic shock—Zoledronate—osteoporosis	0.000495	0.000495	CcSEcCtD
Methylphenidate—Oedema—Zoledronate—osteoporosis	0.000495	0.000495	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000493	0.000493	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000493	0.000493	CcSEcCtD
Methylphenidate—Diarrhoea—Estropipate—osteoporosis	0.000493	0.000493	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Risedronate—osteoporosis	0.000492	0.000492	CcSEcCtD
Methylphenidate—Infection—Zoledronate—osteoporosis	0.000491	0.000491	CcSEcCtD
Methylphenidate—Fatigue—Risedronate—osteoporosis	0.000491	0.000491	CcSEcCtD
Methylphenidate—Insomnia—Pamidronate—osteoporosis	0.00049	0.00049	CcSEcCtD
Methylphenidate—Pruritus—Ibandronate—osteoporosis	0.000489	0.000489	CcSEcCtD
Methylphenidate—Pain—Risedronate—osteoporosis	0.000487	0.000487	CcSEcCtD
Methylphenidate—Constipation—Risedronate—osteoporosis	0.000487	0.000487	CcSEcCtD
Methylphenidate—Angiopathy—Estradiol—osteoporosis	0.000487	0.000487	CcSEcCtD
Methylphenidate—Shock—Zoledronate—osteoporosis	0.000487	0.000487	CcSEcCtD
Methylphenidate—Paraesthesia—Pamidronate—osteoporosis	0.000486	0.000486	CcSEcCtD
Methylphenidate—Diarrhoea—Alendronate—osteoporosis	0.000486	0.000486	CcSEcCtD
Methylphenidate—Asthenia—Calcitriol—osteoporosis	0.000486	0.000486	CcSEcCtD
Methylphenidate—Nervous system disorder—Zoledronate—osteoporosis	0.000485	0.000485	CcSEcCtD
Methylphenidate—Immune system disorder—Estradiol—osteoporosis	0.000485	0.000485	CcSEcCtD
Methylphenidate—Thrombocytopenia—Zoledronate—osteoporosis	0.000484	0.000484	CcSEcCtD
Methylphenidate—Mediastinal disorder—Estradiol—osteoporosis	0.000484	0.000484	CcSEcCtD
Methylphenidate—Dyspnoea—Pamidronate—osteoporosis	0.000483	0.000483	CcSEcCtD
Methylphenidate—Tachycardia—Zoledronate—osteoporosis	0.000483	0.000483	CcSEcCtD
Methylphenidate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000481	0.000481	CcSEcCtD
Methylphenidate—Chills—Estradiol—osteoporosis	0.000481	0.000481	CcSEcCtD
Methylphenidate—Somnolence—Pamidronate—osteoporosis	0.000481	0.000481	CcSEcCtD
Methylphenidate—Skin disorder—Zoledronate—osteoporosis	0.00048	0.00048	CcSEcCtD
Methylphenidate—Pruritus—Calcitriol—osteoporosis	0.000479	0.000479	CcSEcCtD
Methylphenidate—Hyperhidrosis—Zoledronate—osteoporosis	0.000478	0.000478	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000478	0.000478	CcSEcCtD
Methylphenidate—Diarrhoea—Raloxifene—osteoporosis	0.000478	0.000478	CcSEcCtD
Methylphenidate—Dyspepsia—Pamidronate—osteoporosis	0.000477	0.000477	CcSEcCtD
Methylphenidate—Dizziness—Estropipate—osteoporosis	0.000477	0.000477	CcSEcCtD
Methylphenidate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000476	0.000476	CcSEcCtD
Methylphenidate—Oedema—Conjugated Estrogens—osteoporosis	0.000476	0.000476	CcSEcCtD
Methylphenidate—Alopecia—Estradiol—osteoporosis	0.000474	0.000474	CcSEcCtD
Methylphenidate—Infection—Conjugated Estrogens—osteoporosis	0.000473	0.000473	CcSEcCtD
Methylphenidate—Diarrhoea—Ibandronate—osteoporosis	0.000473	0.000473	CcSEcCtD
Methylphenidate—Anorexia—Zoledronate—osteoporosis	0.000472	0.000472	CcSEcCtD
Methylphenidate—Decreased appetite—Pamidronate—osteoporosis	0.000471	0.000471	CcSEcCtD
Methylphenidate—Mental disorder—Estradiol—osteoporosis	0.00047	0.00047	CcSEcCtD
Methylphenidate—Dizziness—Alendronate—osteoporosis	0.00047	0.00047	CcSEcCtD
Methylphenidate—Shock—Conjugated Estrogens—osteoporosis	0.000469	0.000469	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000468	0.000468	CcSEcCtD
Methylphenidate—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000467	0.000467	CcSEcCtD
Methylphenidate—Erythema—Estradiol—osteoporosis	0.000467	0.000467	CcSEcCtD
Methylphenidate—Malnutrition—Estradiol—osteoporosis	0.000467	0.000467	CcSEcCtD
Methylphenidate—Fatigue—Pamidronate—osteoporosis	0.000467	0.000467	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Risedronate—osteoporosis	0.000466	0.000466	CcSEcCtD
Methylphenidate—Tachycardia—Conjugated Estrogens—osteoporosis	0.000465	0.000465	CcSEcCtD
Methylphenidate—Urticaria—Ethinyl Estradiol—osteoporosis	0.000464	0.000464	CcSEcCtD
Methylphenidate—Pain—Pamidronate—osteoporosis	0.000463	0.000463	CcSEcCtD
Methylphenidate—Constipation—Pamidronate—osteoporosis	0.000463	0.000463	CcSEcCtD
Methylphenidate—Diarrhoea—Calcitriol—osteoporosis	0.000463	0.000463	CcSEcCtD
Methylphenidate—Skin disorder—Conjugated Estrogens—osteoporosis	0.000463	0.000463	CcSEcCtD
Methylphenidate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000462	0.000462	CcSEcCtD
Methylphenidate—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000462	0.000462	CcSEcCtD
Methylphenidate—Dizziness—Raloxifene—osteoporosis	0.000462	0.000462	CcSEcCtD
Methylphenidate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00046	0.00046	CcSEcCtD
Methylphenidate—Tension—Estradiol—osteoporosis	0.000458	0.000458	CcSEcCtD
Methylphenidate—Vomiting—Estropipate—osteoporosis	0.000458	0.000458	CcSEcCtD
Methylphenidate—Dizziness—Ibandronate—osteoporosis	0.000457	0.000457	CcSEcCtD
Methylphenidate—Rash—Estropipate—osteoporosis	0.000455	0.000455	CcSEcCtD
Methylphenidate—Dermatitis—Estropipate—osteoporosis	0.000454	0.000454	CcSEcCtD
Methylphenidate—Anorexia—Conjugated Estrogens—osteoporosis	0.000454	0.000454	CcSEcCtD
Methylphenidate—Nervousness—Estradiol—osteoporosis	0.000454	0.000454	CcSEcCtD
Methylphenidate—Urticaria—Risedronate—osteoporosis	0.000453	0.000453	CcSEcCtD
Methylphenidate—Back pain—Estradiol—osteoporosis	0.000452	0.000452	CcSEcCtD
Methylphenidate—Headache—Estropipate—osteoporosis	0.000452	0.000452	CcSEcCtD
Methylphenidate—Vomiting—Alendronate—osteoporosis	0.000451	0.000451	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000451	0.000451	CcSEcCtD
Methylphenidate—Body temperature increased—Risedronate—osteoporosis	0.00045	0.00045	CcSEcCtD
Methylphenidate—Abdominal pain—Risedronate—osteoporosis	0.00045	0.00045	CcSEcCtD
Methylphenidate—Muscle spasms—Estradiol—osteoporosis	0.000449	0.000449	CcSEcCtD
Methylphenidate—Rash—Alendronate—osteoporosis	0.000448	0.000448	CcSEcCtD
Methylphenidate—Insomnia—Zoledronate—osteoporosis	0.000447	0.000447	CcSEcCtD
Methylphenidate—Dermatitis—Alendronate—osteoporosis	0.000447	0.000447	CcSEcCtD
Methylphenidate—Feeling abnormal—Pamidronate—osteoporosis	0.000446	0.000446	CcSEcCtD
Methylphenidate—Headache—Alendronate—osteoporosis	0.000445	0.000445	CcSEcCtD
Methylphenidate—Paraesthesia—Zoledronate—osteoporosis	0.000444	0.000444	CcSEcCtD
Methylphenidate—Vomiting—Raloxifene—osteoporosis	0.000444	0.000444	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Pamidronate—osteoporosis	0.000443	0.000443	CcSEcCtD
Methylphenidate—Dyspnoea—Zoledronate—osteoporosis	0.000441	0.000441	CcSEcCtD
Methylphenidate—Rash—Raloxifene—osteoporosis	0.00044	0.00044	CcSEcCtD
Methylphenidate—Dermatitis—Raloxifene—osteoporosis	0.00044	0.00044	CcSEcCtD
Methylphenidate—Somnolence—Zoledronate—osteoporosis	0.00044	0.00044	CcSEcCtD
Methylphenidate—Vomiting—Ibandronate—osteoporosis	0.00044	0.00044	CcSEcCtD
Methylphenidate—Tremor—Estradiol—osteoporosis	0.000438	0.000438	CcSEcCtD
Methylphenidate—Headache—Raloxifene—osteoporosis	0.000437	0.000437	CcSEcCtD
Methylphenidate—Rash—Ibandronate—osteoporosis	0.000436	0.000436	CcSEcCtD
Methylphenidate—Dermatitis—Ibandronate—osteoporosis	0.000435	0.000435	CcSEcCtD
Methylphenidate—Dyspepsia—Zoledronate—osteoporosis	0.000435	0.000435	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000434	0.000434	CcSEcCtD
Methylphenidate—Ill-defined disorder—Estradiol—osteoporosis	0.000433	0.000433	CcSEcCtD
Methylphenidate—Headache—Ibandronate—osteoporosis	0.000433	0.000433	CcSEcCtD
Methylphenidate—Insomnia—Conjugated Estrogens—osteoporosis	0.000431	0.000431	CcSEcCtD
Methylphenidate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00043	0.00043	CcSEcCtD
Methylphenidate—Vomiting—Calcitriol—osteoporosis	0.00043	0.00043	CcSEcCtD
Methylphenidate—Decreased appetite—Zoledronate—osteoporosis	0.00043	0.00043	CcSEcCtD
Methylphenidate—Agitation—Estradiol—osteoporosis	0.000429	0.000429	CcSEcCtD
Methylphenidate—Nausea—Estropipate—osteoporosis	0.000428	0.000428	CcSEcCtD
Methylphenidate—Body temperature increased—Pamidronate—osteoporosis	0.000428	0.000428	CcSEcCtD
Methylphenidate—Abdominal pain—Pamidronate—osteoporosis	0.000428	0.000428	CcSEcCtD
Methylphenidate—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000428	0.000428	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000427	0.000427	CcSEcCtD
Methylphenidate—Angioedema—Estradiol—osteoporosis	0.000427	0.000427	CcSEcCtD
Methylphenidate—Rash—Calcitriol—osteoporosis	0.000427	0.000427	CcSEcCtD
Methylphenidate—Fatigue—Zoledronate—osteoporosis	0.000426	0.000426	CcSEcCtD
Methylphenidate—Dermatitis—Calcitriol—osteoporosis	0.000426	0.000426	CcSEcCtD
Methylphenidate—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000425	0.000425	CcSEcCtD
Methylphenidate—Headache—Calcitriol—osteoporosis	0.000424	0.000424	CcSEcCtD
Methylphenidate—Somnolence—Conjugated Estrogens—osteoporosis	0.000423	0.000423	CcSEcCtD
Methylphenidate—Pain—Zoledronate—osteoporosis	0.000423	0.000423	CcSEcCtD
Methylphenidate—Constipation—Zoledronate—osteoporosis	0.000423	0.000423	CcSEcCtD
Methylphenidate—Nausea—Alendronate—osteoporosis	0.000422	0.000422	CcSEcCtD
Methylphenidate—Malaise—Estradiol—osteoporosis	0.000421	0.000421	CcSEcCtD
Methylphenidate—Hypersensitivity—Risedronate—osteoporosis	0.00042	0.00042	CcSEcCtD
Methylphenidate—Vertigo—Estradiol—osteoporosis	0.00042	0.00042	CcSEcCtD
Methylphenidate—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000419	0.000419	CcSEcCtD
Methylphenidate—Asthenia—Ethinyl Estradiol—osteoporosis	0.000419	0.000419	CcSEcCtD
Methylphenidate—Syncope—Estradiol—osteoporosis	0.000419	0.000419	CcSEcCtD
Methylphenidate—Nausea—Raloxifene—osteoporosis	0.000415	0.000415	CcSEcCtD
Methylphenidate—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000414	0.000414	CcSEcCtD
Methylphenidate—Pruritus—Ethinyl Estradiol—osteoporosis	0.000413	0.000413	CcSEcCtD
Methylphenidate—Palpitations—Estradiol—osteoporosis	0.000413	0.000413	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000411	0.000411	CcSEcCtD
Methylphenidate—Fatigue—Conjugated Estrogens—osteoporosis	0.000411	0.000411	CcSEcCtD
Methylphenidate—Nausea—Ibandronate—osteoporosis	0.000411	0.000411	CcSEcCtD
Methylphenidate—Loss of consciousness—Estradiol—osteoporosis	0.000411	0.000411	CcSEcCtD
Methylphenidate—Asthenia—Risedronate—osteoporosis	0.000409	0.000409	CcSEcCtD
Methylphenidate—Feeling abnormal—Zoledronate—osteoporosis	0.000408	0.000408	CcSEcCtD
Methylphenidate—Cough—Estradiol—osteoporosis	0.000408	0.000408	CcSEcCtD
Methylphenidate—Pain—Conjugated Estrogens—osteoporosis	0.000407	0.000407	CcSEcCtD
Methylphenidate—Constipation—Conjugated Estrogens—osteoporosis	0.000407	0.000407	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Zoledronate—osteoporosis	0.000405	0.000405	CcSEcCtD
Methylphenidate—Hypertension—Estradiol—osteoporosis	0.000403	0.000403	CcSEcCtD
Methylphenidate—Pruritus—Risedronate—osteoporosis	0.000403	0.000403	CcSEcCtD
Methylphenidate—Nausea—Calcitriol—osteoporosis	0.000402	0.000402	CcSEcCtD
Methylphenidate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.0004	0.0004	CcSEcCtD
Methylphenidate—Hypersensitivity—Pamidronate—osteoporosis	0.000399	0.000399	CcSEcCtD
Methylphenidate—Chest pain—Estradiol—osteoporosis	0.000398	0.000398	CcSEcCtD
Methylphenidate—Myalgia—Estradiol—osteoporosis	0.000398	0.000398	CcSEcCtD
Methylphenidate—Arthralgia—Estradiol—osteoporosis	0.000398	0.000398	CcSEcCtD
Methylphenidate—Anxiety—Estradiol—osteoporosis	0.000396	0.000396	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000395	0.000395	CcSEcCtD
Methylphenidate—Urticaria—Zoledronate—osteoporosis	0.000393	0.000393	CcSEcCtD
Methylphenidate—Discomfort—Estradiol—osteoporosis	0.000393	0.000393	CcSEcCtD
Methylphenidate—Body temperature increased—Zoledronate—osteoporosis	0.000391	0.000391	CcSEcCtD
Methylphenidate—Abdominal pain—Zoledronate—osteoporosis	0.000391	0.000391	CcSEcCtD
Methylphenidate—Diarrhoea—Risedronate—osteoporosis	0.00039	0.00039	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000389	0.000389	CcSEcCtD
Methylphenidate—Dry mouth—Estradiol—osteoporosis	0.000389	0.000389	CcSEcCtD
Methylphenidate—Asthenia—Pamidronate—osteoporosis	0.000389	0.000389	CcSEcCtD
Methylphenidate—Dizziness—Ethinyl Estradiol—osteoporosis	0.000386	0.000386	CcSEcCtD
Methylphenidate—Confusional state—Estradiol—osteoporosis	0.000384	0.000384	CcSEcCtD
Methylphenidate—Pruritus—Pamidronate—osteoporosis	0.000383	0.000383	CcSEcCtD
Methylphenidate—Anaphylactic shock—Estradiol—osteoporosis	0.000381	0.000381	CcSEcCtD
Methylphenidate—Oedema—Estradiol—osteoporosis	0.000381	0.000381	CcSEcCtD
Methylphenidate—Infection—Estradiol—osteoporosis	0.000379	0.000379	CcSEcCtD
Methylphenidate—Urticaria—Conjugated Estrogens—osteoporosis	0.000378	0.000378	CcSEcCtD
Methylphenidate—Dizziness—Risedronate—osteoporosis	0.000377	0.000377	CcSEcCtD
Methylphenidate—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000377	0.000377	CcSEcCtD
Methylphenidate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000377	0.000377	CcSEcCtD
Methylphenidate—Shock—Estradiol—osteoporosis	0.000375	0.000375	CcSEcCtD
Methylphenidate—Nervous system disorder—Estradiol—osteoporosis	0.000374	0.000374	CcSEcCtD
Methylphenidate—Tachycardia—Estradiol—osteoporosis	0.000372	0.000372	CcSEcCtD
Methylphenidate—Vomiting—Ethinyl Estradiol—osteoporosis	0.000372	0.000372	CcSEcCtD
Methylphenidate—Diarrhoea—Pamidronate—osteoporosis	0.000371	0.000371	CcSEcCtD
Methylphenidate—Skin disorder—Estradiol—osteoporosis	0.00037	0.00037	CcSEcCtD
Methylphenidate—Hyperhidrosis—Estradiol—osteoporosis	0.000369	0.000369	CcSEcCtD
Methylphenidate—Rash—Ethinyl Estradiol—osteoporosis	0.000368	0.000368	CcSEcCtD
Methylphenidate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000368	0.000368	CcSEcCtD
Methylphenidate—Headache—Ethinyl Estradiol—osteoporosis	0.000366	0.000366	CcSEcCtD
Methylphenidate—Hypersensitivity—Zoledronate—osteoporosis	0.000364	0.000364	CcSEcCtD
Methylphenidate—Vomiting—Risedronate—osteoporosis	0.000362	0.000362	CcSEcCtD
Methylphenidate—Rash—Risedronate—osteoporosis	0.000359	0.000359	CcSEcCtD
Methylphenidate—Dermatitis—Risedronate—osteoporosis	0.000359	0.000359	CcSEcCtD
Methylphenidate—Dizziness—Pamidronate—osteoporosis	0.000358	0.000358	CcSEcCtD
Methylphenidate—Headache—Risedronate—osteoporosis	0.000357	0.000357	CcSEcCtD
Methylphenidate—Asthenia—Zoledronate—osteoporosis	0.000355	0.000355	CcSEcCtD
Methylphenidate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000351	0.000351	CcSEcCtD
Methylphenidate—Pruritus—Zoledronate—osteoporosis	0.00035	0.00035	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000347	0.000347	CcSEcCtD
Methylphenidate—Nausea—Ethinyl Estradiol—osteoporosis	0.000347	0.000347	CcSEcCtD
Methylphenidate—Insomnia—Estradiol—osteoporosis	0.000345	0.000345	CcSEcCtD
Methylphenidate—Vomiting—Pamidronate—osteoporosis	0.000344	0.000344	CcSEcCtD
Methylphenidate—Paraesthesia—Estradiol—osteoporosis	0.000342	0.000342	CcSEcCtD
Methylphenidate—Asthenia—Conjugated Estrogens—osteoporosis	0.000342	0.000342	CcSEcCtD
Methylphenidate—Rash—Pamidronate—osteoporosis	0.000341	0.000341	CcSEcCtD
Methylphenidate—Dermatitis—Pamidronate—osteoporosis	0.000341	0.000341	CcSEcCtD
Methylphenidate—Dyspnoea—Estradiol—osteoporosis	0.00034	0.00034	CcSEcCtD
Methylphenidate—Headache—Pamidronate—osteoporosis	0.000339	0.000339	CcSEcCtD
Methylphenidate—Somnolence—Estradiol—osteoporosis	0.000339	0.000339	CcSEcCtD
Methylphenidate—Diarrhoea—Zoledronate—osteoporosis	0.000338	0.000338	CcSEcCtD
Methylphenidate—Nausea—Risedronate—osteoporosis	0.000338	0.000338	CcSEcCtD
Methylphenidate—Pruritus—Conjugated Estrogens—osteoporosis	0.000337	0.000337	CcSEcCtD
Methylphenidate—Dyspepsia—Estradiol—osteoporosis	0.000336	0.000336	CcSEcCtD
Methylphenidate—Decreased appetite—Estradiol—osteoporosis	0.000331	0.000331	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Estradiol—osteoporosis	0.000329	0.000329	CcSEcCtD
Methylphenidate—Fatigue—Estradiol—osteoporosis	0.000329	0.000329	CcSEcCtD
Methylphenidate—Dizziness—Zoledronate—osteoporosis	0.000327	0.000327	CcSEcCtD
Methylphenidate—Pain—Estradiol—osteoporosis	0.000326	0.000326	CcSEcCtD
Methylphenidate—Constipation—Estradiol—osteoporosis	0.000326	0.000326	CcSEcCtD
Methylphenidate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000326	0.000326	CcSEcCtD
Methylphenidate—Nausea—Pamidronate—osteoporosis	0.000322	0.000322	CcSEcCtD
Methylphenidate—Dizziness—Conjugated Estrogens—osteoporosis	0.000315	0.000315	CcSEcCtD
Methylphenidate—Vomiting—Zoledronate—osteoporosis	0.000315	0.000315	CcSEcCtD
Methylphenidate—Feeling abnormal—Estradiol—osteoporosis	0.000314	0.000314	CcSEcCtD
Methylphenidate—Rash—Zoledronate—osteoporosis	0.000312	0.000312	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Estradiol—osteoporosis	0.000312	0.000312	CcSEcCtD
Methylphenidate—Dermatitis—Zoledronate—osteoporosis	0.000312	0.000312	CcSEcCtD
Methylphenidate—Headache—Zoledronate—osteoporosis	0.00031	0.00031	CcSEcCtD
Methylphenidate—Vomiting—Conjugated Estrogens—osteoporosis	0.000303	0.000303	CcSEcCtD
Methylphenidate—Urticaria—Estradiol—osteoporosis	0.000303	0.000303	CcSEcCtD
Methylphenidate—Abdominal pain—Estradiol—osteoporosis	0.000301	0.000301	CcSEcCtD
Methylphenidate—Body temperature increased—Estradiol—osteoporosis	0.000301	0.000301	CcSEcCtD
Methylphenidate—Rash—Conjugated Estrogens—osteoporosis	0.0003	0.0003	CcSEcCtD
Methylphenidate—Dermatitis—Conjugated Estrogens—osteoporosis	0.0003	0.0003	CcSEcCtD
Methylphenidate—Headache—Conjugated Estrogens—osteoporosis	0.000298	0.000298	CcSEcCtD
Methylphenidate—Nausea—Zoledronate—osteoporosis	0.000294	0.000294	CcSEcCtD
Methylphenidate—Nausea—Conjugated Estrogens—osteoporosis	0.000283	0.000283	CcSEcCtD
Methylphenidate—Hypersensitivity—Estradiol—osteoporosis	0.000281	0.000281	CcSEcCtD
Methylphenidate—Asthenia—Estradiol—osteoporosis	0.000274	0.000274	CcSEcCtD
Methylphenidate—Pruritus—Estradiol—osteoporosis	0.00027	0.00027	CcSEcCtD
Methylphenidate—Diarrhoea—Estradiol—osteoporosis	0.000261	0.000261	CcSEcCtD
Methylphenidate—Dizziness—Estradiol—osteoporosis	0.000252	0.000252	CcSEcCtD
Methylphenidate—Vomiting—Estradiol—osteoporosis	0.000242	0.000242	CcSEcCtD
Methylphenidate—Rash—Estradiol—osteoporosis	0.00024	0.00024	CcSEcCtD
Methylphenidate—Dermatitis—Estradiol—osteoporosis	0.00024	0.00024	CcSEcCtD
Methylphenidate—Headache—Estradiol—osteoporosis	0.000239	0.000239	CcSEcCtD
Methylphenidate—Nausea—Estradiol—osteoporosis	0.000226	0.000226	CcSEcCtD
